TRICYCLIC ANTIDEPRESSANT PLASMA-LEVELS AFTER FLUOXETINE ADDITION

被引:60
作者
VANDEL, S
BERTSCHY, G
BONIN, B
NEZELOF, S
FRANCOIS, TH
VANDEL, B
SECHTER, D
BIZOUARD, P
机构
[1] CHU BESANCON,SERV PSYCHIAT & PSYCHOL MED,F-25030 BESANCON,FRANCE
[2] CHU POITIERS,PHARMACOL CLIN LAB,F-86021 POITIERS,FRANCE
关键词
TRICYCLIC ANTIDEPRESSANT; FLUOXETINE; PLASMA LEVEL; INTERACTION; DEPRESSED PATIENTS;
D O I
10.1159/000118838
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
After a review of a pharmacokinetic interaction between tricyclic antidepressants (TCA) and fluoxetine the authors report their own data. They confirm the existence of an interaction of TCA with fluoxetine, in clinical practice, but the fluoxetine was not associated in all cases with a marked increase of TCA plasma levels. The increase appeared especially high with clomipramine (n = 4) and imipramine (n = 3), and lower or dose-dependent with amitriptyline (n = 4). The pharmacokinetic change did not induce side effects in the patients, even when the total TCA plasma level increased to 965 (clomipramine) or 785 (imipramine) ng/ml. The authors then discuss the clinical implication and the possible mechanism of action.
引用
收藏
页码:202 / 207
页数:6
相关论文
共 28 条
[1]  
ARANOW RB, 1989, AM J PSYCHIAT, V146, P911
[2]   RAPID DOWN REGULATION OF BETA-ADRENOCEPTORS BY CO-ADMINISTRATION OF DESIPRAMINE AND FLUOXETINE [J].
BARON, BM ;
OGDEN, AM ;
SIEGEL, BW ;
STEGEMAN, J ;
URSILLO, RC ;
DUDLEY, MW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 154 (02) :125-134
[3]   AMITRIPTYLINE PHARMACOKINETICS AND CLINICAL-RESPONSE .2. METABOLIC POLYMORPHISM ASSESSED BY HYDROXYLATION OF DEBRISOQUINE AND MEPHENYTOIN [J].
BAUMANN, P ;
JONZIERPEREY, M ;
KOEB, L ;
KUPFER, A ;
TINGUELY, D ;
SCHOPF, J .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1986, 1 (02) :102-112
[4]   FLUOXETINE INDUCES ELEVATION OF DESIPRAMINE LEVEL AND EXACERBATION OF GERIATRIC NONPSYCHOTIC DEPRESSION [J].
BELL, IR ;
COLE, JO .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1988, 8 (06) :447-448
[5]   FLUOXETINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN DEPRESSIVE-ILLNESS [J].
BENFIELD, P ;
HEEL, RC ;
LEWIS, SP .
DRUGS, 1986, 32 (06) :481-508
[6]   FLUVOXAMINE-TRICYCLIC ANTIDEPRESSANT INTERACTION - AN ACCIDENTAL FINDING [J].
BERTSCHY, G ;
VANDEL, S ;
VANDEL, B ;
ALLERS, G ;
VOLMAT, R .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 40 (01) :119-120
[7]   IMIPRAMINE DEMETHYLATION AND HYDROXYLATION - IMPACT OF THE SPARTEINE OXIDATION PHENOTYPE [J].
BROSEN, K ;
OTTON, SV ;
GRAM, LF .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (05) :543-549
[8]   FLUOXETINE AND NORFLUOXETINE ARE POTENT INHIBITORS OF P450IID6 - THE SOURCE OF THE SPARTEINE DEBRISOQUINE OXIDATION POLYMORPHISM [J].
BROSEN, K ;
SKJELBO, E .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 32 (01) :136-137
[9]   COMBINING FLUOXETINE WITH DESIPRAMINE [J].
DEMASO, DR ;
HUNTER, TA .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1990, 29 (01) :151-151
[10]  
DOWNS JM, 1989, J CLIN PSYCHIAT, V50, P226